Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 54.72% is in line with its 5-year average of 55.68%, around the middle of its 5-year range (50.55%–58.05%).
0.56% below its 12-month average of 55.03%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 55.38%.
GROSS MARGIN
54.72%
GROSS MARGIN AVG TTM
55.03%
GROSS MARGIN AVG 3Y
55.67%
GROSS MARGIN AVG 5Y
55.68%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.56%
CURRENT VS 3Y AVG
-1.70%
CURRENT VS 5Y AVG
-1.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 814 covered companies
CURRENT VS SECTOR MEDIAN
+35.51%
vs the sector median at left
Sotera Health Company
Market Cap
$5.27B
Gross Margin
54.72%
TTM Avg
55.03%
3Y Avg
55.67%
5Y Avg
55.68%
Market Cap
$5.28B
Gross Margin
95.85%
TTM Avg
94.37%
3Y Avg
93.84%
5Y Avg
94.07%
Market Cap
$5.22B
Gross Margin
-6537.01%
TTM Avg
-3376.01%
3Y Avg
-7968.48%
5Y Avg
-11525.78%
Market Cap
$5.17B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-37.83%
Market Cap
$5.06B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$5.05B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
Market Cap
$5.52B
Gross Margin
53.85%
TTM Avg
55.16%
3Y Avg
56.69%
5Y Avg
56.69%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sotera Health Company (SHC) | $5.27B | 54.72% | 55.03% | 55.67% | 55.68% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.28B | 95.85% | 94.37% | 93.84% | 94.07% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | -6537.01% | -3376.01% | -7968.48% | -11525.78% |
| Doximity, Inc. (DOCS)vs › | $5.30B | 88.07% | 89.65% | 88.97% | 88.20% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | 0.00% | 0.00% | 0.00% | -37.83% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 49.52% | 48.04% | 46.91% | 45.73% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.05B | 0.00% | 0.00% | -67.67% | -188.00% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 53.85% | 55.16% | 56.69% | 56.69% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 9.70% | 9.04% | 10.84% | 11.30% |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
54.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 55.38% |
| 2026-03-31 | 51.43% |
| 2025-12-31 | 54.68% |
| 2025-09-30 | 57.04% |
| 2025-06-30 | 56.61% |
| 2025-03-31 | 53.21% |
| 2024-12-31 | 56.64% |
| 2024-09-30 | 55.36% |
| 2024-06-30 | 55.24% |
| 2024-03-31 | 51.22% |
| 2023-12-31 | 58.05% |
| 2023-09-30 | 55.47% |
| 2023-06-30 | 54.68% |
| 2023-03-31 | 50.55% |
| 2022-12-31 | 56.33% |
| 2022-09-30 | 54.69% |
| 2022-06-30 | 56.40% |
| 2022-03-31 | 54.43% |
| 2021-12-31 | 55.52% |
| 2021-09-30 | 55.53% |
| 2021-06-30 | 57.07% |
| 2021-03-31 | 54.38% |
| 2020-12-31 | 55.61% |
| 2020-09-30 | 53.75% |
| 2020-06-30 | 55.83% |
| 2020-03-31 | 51.28% |
| 2019-12-31 | 50.25% |
| 2019-09-30 | 51.32% |
| 2019-06-30 | 50.82% |
| 2019-03-31 | 50.82% |
